TA-HPV immunostimulant: Started investigator-sponsored Phase I trial in the U.K.

Cantab Pharmaceuticals Inc. (CNTBY) Product: TA-HPV immunostimulant, a vaccinia vaccine engineered to contain human papilloma virus genes Indication: Adjunct in treatment of cervical cancer in patient...